Valamehr Bahram 4
4 · FATE THERAPEUTICS INC · Filed Jul 7, 2022
Insider Transaction Report
Form 4
Valamehr Bahram
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-07-06$4.84/sh−2,000$9,680→ 8,704 totalExercise: $4.84Exp: 2025-01-05→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2022-07-06$2.73/sh+5,842$15,949→ 187,676 total - Exercise/Conversion
Common Stock
2022-07-06$4.84/sh+2,000$9,680→ 181,834 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-07-06$2.73/sh−5,842$15,949→ 30,314 totalExercise: $2.73Exp: 2027-01-04→ Common Stock (5,842 underlying) - Sale
Common Stock
2022-07-06$30.07/sh−7,842$235,809→ 179,834 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020.
- [F2]Represents the weighted average sale price of the shares sold ranging from $30.00 to $30.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in footnote 2.
- [F3]This option is fully vested.